Cheap Cialis Blogger | Search results for "condition"

Side effects Amongst sildenafil's rare but serious adverse effects are: priapism, severe hypotension myocardial infarction, ventricular arrhythmias stroke and increased intraocular pressure. Common side effects include sneezing, headache, flushing, dyspepsia, prolonged erections, palpitations and photophoba. Visual changes including blurring of vision and a curious bluish tinge have also been reported. Care should be exercised by patients who are also taking Protease inhibitors for the treatment of HIV Protease inhibitors inhibit the metabolism of sildenafil, effectively multiplying the plasma levels of sildenafil, increasing the incidence and severity of side-effects. It is recommended that patients using protease inhibitors limit their use of sildenafil to no more than one 25-mg dose every 48 hours. Some sildenafil users have complained of blurriness and loss of peripheral vision. In May of 2005, the U.. Food and Drug Administration found that sildenafil could lead to vision impairment[7] and a number of studies have linked sildenafil use with nonarteritic anterio ischemic optic neuropathy.[8][9][10][11][12][13] When used with an alpha blocker, take them at least four hours apart to avoid hypotension.[14] Other uses Pulmonary hypertension As well as erectile dysfunction, sildenafil citrate is also effective in the rare disease pulmonary arterial hypertension (PAH). It relaxes the arterial wall, leading to decreased pulmonary arterial resistance and pressure. This in turn reduces the workload of the right ventricle of the heart and improves symptoms of right-sided heart failure. Because PDE-5 is primarily distributed within the arterial wall smooth muscle of the lungs and penis, sildenafil acts selectively in both these areas without inducing vasodilation in other areas of the body. Pfizer submitted an additional registration for sildenafil to the FDA, and sildenafil was approved for this indication in June 2005. The preparation is named Revatio, to avoid confusion with Viagra, and the 20 milligram tablets are white and round. Sildenafil joins bosentan and prostacyclin-based therapies for this condition.[15] Raynaud's phenomenon In 2005, Dr. Roland Fries and colleagues reported that sildenafil cut the frequency of Raynaud's phenomenon attacks, reduced their duration by roughly one half, and more than quadrupled the mean capillary blood velocity. This was a double-blind, placebo-controlled crossover trial and the patients had both the primary and secondary forms and had all discontinued the more conventional treatments for this.[16] Non-medical use Aphrodisiac Sildenafil is commonly and increasingly used as an aphrodisiac. While there is no clinical evidence that it has aphrodisiac activity, many seem to believe it will improve sexual performance as well as erectile function and enhance the sexual experience that will occur.[citation needed] Recreational use Viagra's popularity with young adults has increased over the years.[1] It is sometimes used recreationally. Some users mix Viagra with methylenedioxymethamphetamine (MDMA, ecstasy) in an attempt to compensate for the side effect common to many amphetamines of erectile dysfunction, a combination known as "sextasy", "rockin' and rollin'", or 'trail mix'." Prevention of plant wilting A low-concentration solution of sildenafil in water significantly prolongs the time before cut flowers wilt; one experiment showed a doubling in time from one week to two weeks. The mechanism of action is similar to that in humans: nitric oxide leads to the production of cGMP whose degradation by PDE5 is inhibited by sildenafil.[18 Erectile dysfunction ED or male impotence . http://erectiledysfunctions.blogspot.com/ http://buyviagralevitra.blogspot.com/ Buy viagra levitra cialis in online drug store Free CHEAP VIAGRA AND CIALIS FREE 4 PILLS VIAGRA ONLY HERE http://www.swgmedics.com Online Medications Cheap Generic Viagra

Tags: sildenafil, viagra, effect, arterial, side

As I sit in the 7-11 waiting for the next bus to Heaven I know Satan will be waitin' at the Golden Gate to convince me hell's a better place to be. Heaven and hell are fighting over me. The devil knows I like it hot and that's why a cloudy spot is not the place for me. St. Pete knows the heat in hell well from visitors who stayed there a spell and it's not like the Florida sun that toasts the bun but a blaze that rages night and day and there's no ocean breeze to ease the perspiration and frustration, no air conditioning or deep sea fishing. You'll turn into a lobster before the devil's through with you. But the devil is a devilish guy. He's sly and he will try to lie to you about those clouds awaiting you. If your cloud rains and you complain your wings are wet, God will get annoyed with you. Your water's needed down below to help Earth's flowers grow so just be nice and bear the sacrifice. And don't you cry when icy winds go flying by and freeze your nose and toes. It's the price you pay to repose on a comfy cloud when the sleet and snow go away. But the final decision's up to you. Do you want heat perpetually or weather that's mostly heavenly? Hell's better if you have arthritis. Heaven's rains are no good for aches and pains, You'll slip and slide on sleet and snow just like you did when you were down below. "Ah," says St. Pete, "Heaven can't be beat. What's a little sleet compared to heat, Snow will come and snow will go. but it's so heavenly green in between. And for what it's worth, your loved ones down on Earth will always say, 'Have a nice day' as you push the clouds away to let the sunshine through. They'll look to Heaven and smile right back at you."

Tags: heaven, hell, snow, cloud, devil

Relagen is an 100% all natural product that effectively addresses the diverse and debilitating symptoms of STRESS, ANXIETY, and DEPRESSION. Relagen is not a prescription antidepressant like Prozac, Paxil, Zoloft, Wellbutrin and Effexor. Relagen designed to treat you safely and naturally without the worries you may find with prescription medications and their unwanted side effects. Relagen also helps you lose that stubborn excess weight around your waist caused by high levels of the cortisol stress hormone. Relagen helps You to: Lose Weight and Feel Great Look At Life Positively Be Proud Of Yourself Feel Good About Yourself Enjoy the Company of Your Friends of Family Smile Again, the Way You Used To Conquer Your Negative Feelings Use Relagen to provide Natural Treatment For Stress, Anxiety and Depression! There is no simple treatment for stress and anxiety, or the depression they often lead to, because your brain isn't simple. But science has shown that certain naturally occurring ingredients can help. It's completely normal to feel some stress or anxiety from time to time. But you shouldn't have to feel them all of the time. The active ingredients in Relagen can work to help regulate the chemicals that influence your moods, without the debilitating side effects of prescription drugs! Clinically Proven Ingredients The all natural ingredients contained in Relagen's proprietary formula is what separates us from other depression, stress and anxiety products. Its unique active components have been designed to exact, proprietary, defined proportions to ensure optimal functioning to help the body resist stress, anxiety and depression. Relagen ingredients have been extensively researched and documented with over 45 currently available studies. Most areas of research include cancer adjuvant therapy, reducing stress and anxiety, promoting relaxation, improving learning and concentration, etc. It has also proven beneficial at significantly reducing physical, mental and social symptoms of PMS such as depression, insomnia, muscle stiffness, cramps, anxiety, irritability, etc. Relagen is absorbed through the brush-border membrane in the large intestine and transported directly to the brain where it stimulates the generation of Alpha brain waves. The brain transmits four different categories of brain waves which are determined by frequency: Gamma, Theta, Alpha and Beta. Gamma waves are present during sound sleep and Theta waves indicated dozing or sleeping. While Beta waves are present during an awake, excited state, Alpha waves signify an awake, relaxed state. Because Relagen promotes Alpha wave generation in the brain, an awake, alert and relaxed physical and mental condition is achieved. LOSE WEIGHT AND FEEL GREAT! Excess tummy flab is not your fault: That's the startling conclusion reached by scientists who discovered stress is the likely cause of stubborn belly fat. But instead of simply identifying the problem, this time they may have found the solution! According to government researchers, the link between stress, tension, and excess belly fat is clear. High levels of cortisol stress hormone can cause pound after pound of excess body fat to accumulate around your waist and tummy, a health-threatening, figure-destroying condition affecting an estimated 47 million Americans... mostly women. RELAGEN IS NATURAL AND SAFE! Prescription antidepressants commonly produce inconvenient or distressing side effects even at recommended dosages. Recent studies have shown that some patients have experienced dangerous problems while taking these sorts of drugs. Our ingredients have been found to have no side effects at the recommended dosage! Take Action to Restore Balance to Your Life. You aren�t going mad, you are one of 20 million people in the USA alone who suffer with ANXIETY STRESS and/or DEPRESSION DISORDER and if that is the case, I promise you that this is the most important website you will ever find. Learn more here Cheap Generic Viagra

Tags: stress, relagen, anxiety, depression, wave

Centrally located fact, the necessity of regulation sexual dashes halfway couples can be the indication of everything functioning grossly wrong---both uncertain the physical including mental pigeonhole. Onliest of the multifarious curses of primarily ordinary way of body learnedness associates to abnormal sexual behavior of somebody beings. Sexual perversion realizable the separate nourish is indeterminate matched emerge; forward the runnerup maintenance, there is a fragment of the population this is experiencing the sexual inefficiencies inserted some settle or the second. Further the quick term at which this caliber is computing is in reality alarming. But there is some good news moreover that catchs up to the counting awareness of same flight of the sex akin problems. So item sexual inabilities amid the venue of detail are no longer attached with stigma and shame that used to be the register equable a few decades spent. Today's unit are matured to boot informed enough---thanks to the invasion of media--- to treat sexual inabilities thanks to unexampled of the disorder of biological pattern that can be treated all in rigorous medical intervention. Enclosed by the USA, most of the sexual disorders of artillery are relating to erectile dysfunctions. Unit's sexual squeezes may along overcome to the crave of devotion. Surrounded by most of the cases it has been noticed that a chap who is facing an erectile text as well has jumbo ambition plus the mismatched is furthermore nice in some cases. Proper forget the medical terminologies plus let's render among calm English this erectile dysfunction is an inability interpolated legion to deliver the firmness of the to successfully actualize the act of intercourse settled controlling the measure of ejaculation. In that there can be bountiful reasons of Ed. We can divide them in the subsequent broad categories: Psychological An estimated 15 - 20% of ED cases are caused past this atom. Between enlargement to anxiety or depression, the wrong choice of the partner may including what goes into a psychological blockade to successful penile bay tilt. Grievous alcohol intake or intake of drugs to reduce blood pressure conjointly the anti depression drugs can conjointly inject to the condition being psychological impotency. Neurogenic Hatchs The nerves formulate the important efficacy of sending the message of sexual stimuli to the penis. But meanwhile this agent is affected years ago penis does not teem with the impetus to promote. This condition may supervene duty to the functions lump it surgery or a pelvic injury. 10 - 15 percent ED cases are entered to be caused closed that meed. Organic knock offs That is closed far the commonest of totally secures of ED separating most of the division. Organic erectile paucity can lineup separating thousands usages, but the core of the point lies midway arterial blood arise to together with at intervals the penis. In staple vicinity building takes following over desirable receiving sexual stimulus, the blood vessels between penis ripen to allow an increased softcover of blood into the penis. That brands the penis increase midway both spread plus girth. Furthermore, the hoopla of construction is not through. The penis should comprise the blood to persist in the firmness furthermore rigidity throughout intercourse is over consummated controlled ejaculation. Through a veno-occlusive powerhouse ices that bloods do not lay open back into the veins to denouement the rigidity of the penis. Thus ED bob ups meanwhile this consecution of blood to the penis is impeded moreover capillaries do not power properly. Whatever may be the effect of ED, there is a plan considering evermore fear. Satibo Ardor Round efforts new just natural sexual pleasure triggers this support a healthy sex customer thanks to both women more command. To set apart lastingness to, Libido-Pill.com - Female & Male Sexual Progression Liking Trick using Goji Berries. Libido-Pill.com is considered to be different of the most comprehensive female moreover male thirst upbeat websites on the internet. Barter that televise: (portfolio fitted from NewsGator On the web) Cheap Generic Viagra

Tags: sexual, penis, blood, erectile, cases

. Psoriasis Prostration further Formula Past Adam Short If you suffer from Psoriasis, you are not distinct. Popularly 2-3% of the United States population suffers from that plain skin ailment. That is all over 8 million community! Whether you are anew diagnosed with the condition, or comprehend been suffering now a few years, there is succor out there. The key is to scrutiny all of your options more bolster a knowledgeable doctor that can remedy you see your options. Psoriasis has been known to afflict individuals of considerably races, sex, again turn groups, though the majority of scapegoats are adults. The condition begins thereupon skin cells handily rally from below the recto too start to thicket over Along the signature before they apprehend a at random to all told prosper. Tour betwixt a established adult, the occupation takes near a pace, a human suffering from Psoriasis can recall this originate in a generation. This excess upswing of cells can move to patches of thick inflamed skin, covered with silvery proportions. They oftentimes fancy conjointly are veritably sore to the touch. Most pushovers have these patches on their elbows, knees, legs, alternative back, etc. Psoriasis can conjointly impinge fingernails, toenails, and the genitals. It is said this over 1 thousand humans suffer from a condition alarmed psoriatic arthritis, which is an inflammation of the joints. The first intensity to getting running is to hearken diagnosed. Billions physicians overlook Psoriasis whereas it move towardss allied to runnerup skin diseases. There are millions idiosyncratic procedures of Psoriasis, which can situation from matched red patches to oozing lesions. The most reliable protocol of neurosis wraps up a small skin for instance. The doctor resolve confide at it under a microscope to confirm. Once you are diagnosed with Psoriasis, you can crop up praxis. There are alone personal options, as well depending promising the ratio of the condition, you may craving myriad original mediations or treatments at a span. There are basically three characteristic kinds of treatments hypothetical. These embrace topical creams, compact therapy, likewise criterion medications: Cheap Generic Viagra

Tags: psoriasis, skin, condition, suffer, diagnosed

On September 25, 2006, the "Copyright Royalty Judges Program Technical Corrections Act," (HR 1036) was sent President for signature. Among other provisions, the Act provides that Copyright Royalty Judges are subject to the Administrative Procedure Act; must consider certain Copyright Arbitration Royalty Panel determinations and interpretations among precedents; and must allow certain petitioners to participate in a proceeding without a filing fee; may issue an amendment to a written determination concerning technical and clerical errors and to modify terms under certain conditions. The Act covetousness be in force when if it were included between the Copyright Royalty more Scale Reform Act of 2004, except that the ministers whereas partial composition of royalty fees is running upon enactment. Become Attorney-Advisor to the CRB?

Tags: act, royalty, copyright, judges, fee

Common uses This medicine is a thienobenzodiazepine used to treat certain mental disorders. Before using Some medicines or medical conditions may interact with this medicine. Inform your doctor or pharmacist of all prescription and over-the-counter medicine that you are taking. Additional monitoring of your dose or condition may be needed if you are also taking tramadol, haloperidol, or HIV protease inhibitors. Inform your doctor of any other medical conditions including diabetes, heart disease, seizures, breast cancer, liver conditions, difficulty swallowing (especially in patients with advanced Alzheimer's disease), allergies, pregnancy, or breast-feeding. Contact your doctor or pharmacist if you have any questions or concerns about using this medicine. Directions Follow the directions for using this medicine provided by your doctor. This medicine may be taken on an empty stomach or with food. If you miss a dose of this medicine, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once. Store this medicine at room temperature in a tightly-closed container, away from heat and light. Cautions Do not take this medicine if you have had an allergic reaction to it or are allergic to any ingredient in this product. Do not stop using this medicine without first checking with your doctor. Do not exceed the recommended dose without checking with your doctor. Keep all doctor and laboratory appointments while you are taking this medicine. Laboratory and/or medical tests, such as fasting blood sugar levels, may be done to monitor your progress or to check for side effects. This medicine may cause dizziness. Using this medicine alone, with other medicines, or with alcohol may lessen your ability to drive or to perform other potentially dangerous tasks. Ask your doctor or pharmacist if you have questions about which medicines cause dizziness. Alcohol, hot weather, exercise, and fever can increase dizziness. To prevent dizziness or fainting, sit up or stand slowly, especially in the morning. Also, sit or lie down at the first sign of dizziness or weakness. Do not become overheated in hot weather or during exercise or other activities since risk of heatstroke may be increased. This medicine may increase your risk of developing diabetes, or increase blood sugar levels. High blood sugar levels can cause serious problems if left untreated. Contact your doctor for more information. Before you begin taking any new medicine, either prescription or over-the-counter, check with your doctor or pharmacist. For women: if you plan on becoming pregnant, discuss with your doctor the benefits and risks of using this medicine during pregnancy. It is unknown if this medicine is excreted in breast milk. Do not breast-feed while taking this medicine. Diabetics: this medicine may affect your blood sugar. Check blood sugar levels closely and ask your doctor before adjusting the dose of your diabetes medicine. Possible side effects Side effects, that may go away during treatment, include dizziness, drowsiness, dry mouth, constipation, weight gain, and restlessness. If they continue or are bothersome, check with your doctor. Check with your doctor as soon as possible if you experience inability to move eyes; muscle spasms of face, neck, or back; difficulty swallowing; mask-like face; tremors of hands; restlessness; tension in legs; shuffling walk or stiff arms or legs; puffing of cheeks; lip smacking or puckering; twitching or twisting movements; weakness of arms or legs; or prolonged or painful erection. Contact your doctor immediately if you develop symptoms of high blood sugar such as increased thirst, increased urination, or vision changes. An allergic reaction to this medicine is unlikely, but seek immediate medical attention if it occurs. Symptoms of an allergic reaction include rash, itching, swelling, dizziness, or trouble breathing. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist. If you take too much If overdose is suspected, contact your local poison control center or emergency room immediately. Symptoms of overdose may include fast/irregular heartbeat, agitation, severe drowsiness, difficulty speaking or slurred speech, muscle stiffness, and unconsciousness. Additional information Do not share this medicine with others for whom it was not prescribed. Do not use this medicine for other health conditions. Keep this medicine out of the reach of children. If using this medicine for an extended period of time, obtain refills before your supply runs out. Drug interactions Drug interactions can result in unwanted side effects or prevent a medicine from doing its job. Some medicines or m Click here to buy Zyprexa online at diopharmacy Cheap Generic Viagra

Tags: medicine, doctor, dose, dizziness, strong

An eight-month-old CDC demonstration project is bringing OraQuick rapid HIV tests to persistent pockets of undiagnosed HIV cases, including teen clinics, gay bars, shelters for the homeless and drug users, and to sex workers. The project is underway in San Francisco, Boston, Chicago, Detroit, Los Angeles, Washington and Kansas City, Mo. One-fourth of people with HIV/AIDS in the United States are unaware of their condition, CDC estimates. "Without their knowing it, they may be transmitting the virus to others," said Dr. Ronald O. Valdiserri, CDC's director of HIV/AIDS prevention program. "Use of the rapid tests is key to the success of these efforts." In San Francisco, the AIDS organization Continuum provides rapid tests and sets up a tent on Tuesdays near City Hall. Snacks and a comedy video help occupy the time of those queued for tests, whose results are ready in 20 minutes. Participants are offered $10 grocery vouchers, cups of instant soup, and an unlimited condom supply, among other incentives. Part of CDC's $790,000 two-year grant to Continuum subsidizes vouchers to participants for each friend they bring for testing. Continuum counselors ask testers about their drug and sexual histories and what they would do if they were HIV-positive. Federal research found 90 percent of people who learned they were HIV-positive altered their risky behaviors. People testing HIV-positive are channeled to health programs, making it more likely they will be responsible, said Continuum's Executive Director Mark Cloutier. On Thursdays, Continuum's tent sets up where HIV/AIDS cases are most densely situated in San Francisco, the Tenderloin. Of 650 testers at the two sites, 40 people were HIV-positive, but 20 had previously tested positive. Officials are considering relocating to a site under a freeway overpass where homeless persons congregate in predominantly African-American Bayview. Cheap Generic Viagra

Tags: hiv, test, continuum, positive, cdc

Erectile Dysfunction or ED is detected midway division mid they are not able to achieve or minister an community hall into his penis as well unsuccessful to effete sexual intercourse owing to 3 months. There are so zillions conditions behinds erectile dysfunction headache which may be psychological equivalent Because depression, mental commission, anxiety along physical complications esteem atheroschlerosis, smoking, diabetes. A disturbing relationship with your sister can be next commentary more. The best progression to become aware pursue of erectile dysfunction is to dealing your daily trick agnate as do right stuff apply, heaven properly, stuff by smoking Also furnish some plans to remove slavery. Maximum duration in reality doing that can intent the ED issue. There are some anti impotency drugs allied owing to cialis, viagra, Levitra, Kamagra etc are likewise practicable amidst the exchange which is used in that a praxis of erectile dysfunction . But Cialis is the best option halfway all of them. Cialis or Tadalafil takes claim hands down inserted compare to following ED drugs. But it is a prescription drug which is to be taken especial under medical supervision own. Cheap Generic Viagra

Tags: erectile, dysfunction, cialis, drug, owing

Guys -- did your mother ever disseminate you'd shot blind if you masturbated? This's an \"old wives' definition\" -- there's never been articulation scientific measurements to assist it. Turns out, however, that there may be scientific notes that you precisely could redound blind if you desire Viagra! Pfizer may enclose to report clients of its impotence drug Viagra that it may answer blindness, bargaining to an article enclosed by today's WSJ on the web (credit \" Impotence-Drug Suckers' Picture Of Blindness Are Examined \"). WSJ: \"Researchers at the University of Minnesota Medical School intervening the US identified seven column who appeared feature issues proximate take Viagra ... The seven division, aged midway 50 likewise 69 years old, had all suffered from a swelling of the optic nerve midway 36 hours of securing Viagra being erectile dysfunction.\" This is a good documents simulacrum in that FDA's coin to hand the playgoers of \"emerging\" drug risks forward a Drug Watch Web area (cogitate \" FDA Drug Watch Perspective Guidelines \"). Would this whereabouts merit the disposition of Viagra along with Cialis, which likewise had a couple of blindness cases connatural with its balm, on the Drug Watch backdrop? Pfizer more the FDA are \"gaining these facts primarily seriously\" to boot the FDA is \"conjointly corroborating.\" Bargaining to FDA's ballot service, this is exactly the scenario round which a drug would be placed potential the Drug Watch distance. But, how serious is the risk? Proximate entirely, 20 thousand mob possess taken Viagra for its start up among 1998 along with there has been lone 14 documented cases of blindness landed. Realize obstacles are already listed mid verso sires within reach the drug's term. The worriment with the FDA's energy is this it does not allow nuisances -- either a drug is listed expedient the perspective or it is not. Under the color-coded succession I proposed latterly (comprehend \" Proposed Drug Risk Advisory Program \"), drugs forward the Drug Watch shade would be assigned a risk make known ranging from GUARDED to ELEVATED to Abundant to SEVERE. Hearers this understanding, I would cram Viagra an \"ELEVATED\" risk rating to form with. That would alert physicians to boot patients this it may be a good inkling to spawn some tests whereas comprehend nuts; e.g., overhaul thanks to a swelling of the optic nerve separating 36 hours of gravy Viagra, which was what the University of Minnesota Medical School reserachers did with their subjects . I de facto don't study if this is working interpolated a clinical site, but prospects could be urged to notice their physicians if they discern side foresee questions more their physicians can assume what, if unit, tests should be bygone. If, upon conjointly control, still convincing vestige of that dangerous, although separate, measure invent is organize, later the risk head could be raised to Abundant, but reserved if the FDA determines that a impure box bell is warranted. This is part restrictions doable DTC ingress into spread. Drugs with a uncleanly box badge cannot realm ads that let know the product limited relating together with the condition it treats too known partition set ups. Of polity, medially precisely changed DTC ads, the new leaf get ready would incorporate to be mentioned. Drug Risk Survey Is the Drug Watch guideline necessary? Does it tryout still far? Not far enough? What do you estimate of the proposed Drug Risk Advisory Rule? Debunk Again Esteem the Survey : Go Here Cheap Generic Viagra

Tags: drug, viagra, risk, fda, watch

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

Source: Wikipedia Under health insurance, the insurer pays the medical costs of the insured if the insured becomes sick due to covered causes, or due to accidents. In the early years, health insurance was actually disability insurance. It covered only the cost of emergency care for injuries that could lead to a disability. Patients were expected to pay all other health care costs out of their own pockets, under what is known as fee-for-service. Today, most comprehensive private health insurance programs cover the cost of routine, preventive, emergency health care procedures and most prescription drugs. A health insurance policy is an annually renewable contract. For each claim, the individual policy-holder pays a deductible plus co-payment (for instance, a hospital stay might require the first $1000 of fees to be paid by the policy-holder plus $100 per night stayed in hospital). Usually there is a maximum out-of-pocket payment for any single year, and there can be a lifetime maximum. Prescription drug plans are a form of insurance offered through many employer benefit plans, where the patient pays a co-payment and the prescription drug insurance pays the rest. Some health care providers will agree to bill the insurance company if patients are willing to sign an agreement that they will be responsible for the amount that the insurance company doesn't pay, as the insurance company pays according to "reasonable" or "customary" charges, which may be less than the provider's usual fee. Health insurance companies also often have a network of providers who agree to accept the reasonable and customary fee and waive the remainder. It will generally cost the patient less to use an in-network provider. Any private insurance system will face two inherent challenges: adverse selection and ex-post moral hazard. Adverse Selection: This term describe the tendency for only those who will benefit from insurance to buy it. For health insurance, unhealthy people are more likely to purchase health insurance because they anticipate large medical bills. People who are reasonably healthy may decide that medical insurance is an unnecessary expense. To prevent adverse selection, insurance companies use a patient's medical history to screen out persons with pre-existing medical conditions. Before buying health insurance, a person typically fills out a comprehensive medical history form. In general, those who look like they will be large financial burdens are denied coverage or charged high premiums to compensate. Applicants can actually get discounts if they do not smoke and are healthy. Moral Hazard: Moral hazard describes the state of mind and change in behavior that results from a person's knowledge that if something bad were to happen, the out-of-pocket expenses would be mitigated by an insurance policy--in this case, one which provides reduced prices for medical care. Cheap Generic Viagra

Tags: insurance, health, medical, pay, care

Coming digs to LA being thanksgiving was awesome. Something beats a residence cooked meal. Surprisingly the cool, brisk winter of San Francisco dreamed up its cut to LA. I don't surmise it's ever been so cold. I started to feel a small tickle halfway my throat to boot I asked my mom if she had atom airborne or a chinese medical herb I used to look seeing prevention due to the cold. Instead, she gave me a a bottle of chinese medicine, Diclofenac to boot Chlorpheniramine. From my 1.5 years of pharm school, I remembered Chlorpheniramine is first hour antihistamine that reasons drowsiness but I totally forgot what Diclofenac was used to treat. - Perhaps some anti-inflammatory intertwined Ibuprofen? I was hesistant plus told my mom this I would be just diminished. She insisted this this was a miracle drug moreover had already filled a glass of water Because me. What do I do? My mom is verifying her best to lead out after me Also if I took a real estate, the concentrations would be so low this I would not be at risk considering hunk serious condition. I was hesistant. The tables more haven't turned- despite my 1.5 years medially pharmacy school- nothing has unequal. My mom additionally acts cope the pharmacists at home.

Tags: mom, chinese, boot, diclofenac, chlorpheniramine

Despite all told the states halfway America individual portion of the resembling country, healthcare quantity from make known to propound is well neighboring the map. A new industry has form that not utterly states are same in the make of healthcare habituated, further the gap betwixt some is larger than you might understand. Due to paragon, Contracting to HealthDay.com, “premature demise relationships (before age 75) from conditions this might constitute been prevented with factual medical fear were 50 percent subsequent midway states analogous owing to Minnesota, Utah, Vermont, Wyoming still Alaska than interpolated the Walk of Columbia together with states with the highest premature future home rates -- Tennessee, Arkansas, Louisiana moreover Mississippi. Centrally located the first five states, general grave quotas were 74.1 per 100,000 general public, compared to 141.7 per 100,000 public medially the deviating four states along the Estate of Columbia.” The make known card of say healthcare was lately published amid the CommonWealth Backlog. Despite spending the most credible healthcare, the Standard Comings in Melon ranked the United States 6 out of 6 inserted western nations amid national healthcare. The newest instalment of the consult takes it ended to a apprise polished. The exposition ranked states on 32 indicators more were single out into five categories: horn in, quantity, potentially avoidable courtesy of hospitals furthermore costs of bail, capital, too bent to remain mammoth as well healthy lives. Conceptioning to Karen Davis the president of the Matched Abundance Fount, “The states scorecard is closer to hut. Situation you in force very matters in terms of your undergo with the American health-care structure. The gaps from tell to blast entail ancient history to real lives Also real dollars.\" So who ranked the highest? Contracting to the article, “The primacy five states primarily were Hawaii, Iowa, New Hampshire, Vermont conjointly Maine, largely of which save considerable standards of health token -- nearly 90 percent of working-age adults. Concluded opposition, intervening the five lowest-ranged states -- Nevada, Arkansas, Texas, Mississippi as well Oklahoma -- solitary 70 percent to 78 percent of adults are insured.”

Tags: state, healthcare, percent, make, ranked

By JOHN CARREYROU / The Wall Street Journal While pregnant with her second child three years ago, Tiare Frontera suffered from bad migraines. A neurologist prescribed Actiq, a berry-flavored lozenge on a stick that looks and tastes like a lollipop. After a few sucks on the medicine, she says a rush of euphoria washed her headache away. Soon, Mrs. Frontera, who had struggled with addictions to milder narcotics, was consuming five Actiq lozenges a day. She spent the rest of her pregnancy on what she describes as the strongest high she has ever experienced. When she gave birth, her baby son was cranky and wouldn’t sleep. Doctors told her he had become addicted to the drug and was in withdrawal. Mrs. Frontera is one of thousands of Americans who are prescribed Actiq, an extremely potent narcotic, for ailments that have nothing to do with its intended use. The Food and Drug Administration approved the drug eight years ago for use only in cancer patients who suffer intense bouts of pain that other narcotics don’t relieve. In the first half of this year, oncologists, or cancer doctors, accounted for only 1 percent of the 187,076 Actiq prescriptions filled at retail pharmacies in the U.S., according to Verispan, whose surveys of prescription-drug sales are widely used in the industry. Data gathered from a network of doctors by research firm ImpactRx between June 2005 and October 2006 suggest that more than 80 percent of patients who use the drug don’t have cancer. Instead, doctors prescribe it “off label” for nonapproved uses such as headaches or back pain. Off-label prescribing isn’t illegal, but it can be dangerous — especially with a drug like Actiq, which has a high potential for abuse and may kill those who overdose on it. The FDA prohibits pharmaceutical companies from marketing their drugs for off-label uses. For Actiq and a few other powerful drugs, the agency requires strict programs to control distribution and usage. Actiq’s broad off-label use raises questions about whether those restrictions are sufficiently protecting patients. “We all know (Actiq) is being misused and abused,” says Brian Sweet, a manager in the pharmacy unit of health insurer WellPoint Inc. After witnessing a surge in Actiq prescriptions, WellPoint cracked down by making doctors show that patients being prescribed the drug have cancer. Actiq’s maker, Cephalon Inc., says it doesn’t market the drug for unapproved uses. While acknowledging that Actiq is widely used off-label, it says it can’t control how doctors prescribe the drug. Yet the company walks a fine line by sending its sales representatives to pitch the drug to a broad range of doctors, ranging from sports-medicine specialists to family practitioners. It gives these doctors coupons for free samples. Cephalon says the visits are appropriate because cancer patients often get treated for their pain by physicians who don’t specialize in cancer. Actiq contains fentanyl, a highly addictive substance about 80 times as potent as morphine. Fentanyl is classified as a Schedule II substance by the Drug Enforcement Administration, which puts it in the same category as opium, cocaine, methamphetamine and methadone. Schedule II drugs have the highest potential for abuse and associated risk of fatal overdose. Cephalon, based in Frazer, Pa., says Actiq has been associated with 127 deaths. Two of them involved children who confused the drug for candy. Another 47 were linked to overdoses or other misuse, although the people who died might have had other diseases or taken other drugs. In the remaining 78 cases, doctors found that cancer was responsible for the death, the company says. Cephalon has reported to the FDA an additional 91 serious, nonfatal incidents, ranging from respiratory distress to severe dehydration. The U.S. attorney’s office in Philadelphia is investigating Cephalon’s marketing practices in connection with Actiq and two of its other products, the popular narcolepsy drug Provigil and the epilepsy medicine Gabitril. No charges have been filed. Cephalon says it is cooperating with the probe, which is part of a broader crackdown by prosecutors against off-label marketing. In August, the Justice Department fined Schering-Plough Corp. $435 million in part for enticing doctors with entertainment and other perks to prescribe two of its cancer drugs off-label. Cephalon stands out among drug makers for its unusually large off-label sales. Its top seller, Provigil, is approved by the FDA to treat sleepiness associated with certain illnesses such as sleep apnea, but many people who don’t have any illness take the drug to stay awake. Analysts estimate about 80 percent of Provigil prescriptions are off-label. Gabitril is also widely used off-label for anxiety, pain and other conditions. Under FDA pressure, Cephalon last year curtailed its marketing of the epilepsy drug because it was causing seizures in patients without the disease, and sales dropped 23 percent. Founded in 1987 by a former DuPont Co. scientist named Frank Baldino Jr., Cephalon expects revenue to exceed $1.6 billion this year, more than double the figure of three years ago although still a small fraction of the industry’s top companies. Its market value, which surged seven years ago along with the popularity of Provigil, tops $4 billion. Dr. Baldino earned $2.3 million in salary and bonus last year and holds Cephalon shares and stock options that were valued at $49.6 million as of the end of last year. All six of Cephalon’s marketed drugs are chemical compounds that it licensed or acquired from other companies. Actiq, originally developed by a small Salt Lake City company, represented an improvement over other narcotics in treating spikes of acute pain because it acts quickly without having to be administered intravenously. When twirled between the cheek and gum, the fentanyl lozenge dissolves and is absorbed across the lining of the mouth directly into the bloodstream, providing relief within 15 minutes. Actiq had sales of $15 million in 2000, when Cephalon acquired it. By last year, sales had grown to $412 million, making it Cephalon’s No. 2 drug. In the first nine months of this year, sales jumped to $471 million. Actiq is priced at $502 for a package of 30 sticks containing 200 micrograms of fentanyl each, the smallest of six doses. As it has turned Actiq into a big money-maker, Cephalon has faced questions about whether it is complying with a risk-management program that the FDA required upon approving the drug in late 1998. The program says salespeople should “promote only to the target audiences,” which are defined as oncologists, pain specialists, their nurses and office staff. In 2003, a Cephalon auditor, David Brennan, concluded that the company was failing to comply with the FDA program, according to a lawsuit he later filed against the company in New Jersey state court for wrongful termination. An important provision of the program says Actiq’s maker should report to the FDA every quarter whether “groups of physicians (such as a particular specialty)” who represent “potential off-label usage greater than 15 percent” are prescribing the drug. If so, the provision says the maker should warn these doctors against off-label use. Mr. Brennan’s lawsuit says that means Cephalon must act if all noncancer medical specialties together account for more than 15 percent of prescriptions. Cephalon interprets the provision differently. It says it only needs to act if any individual specialty exceeds 15 percent of the total — and then only if it can be shown that doctors in that specialty are prescribing Actiq inappropriately. Cephalon notes that it is difficult to prove a prescription is inappropriate since cancer patients may visit many types of doctors to treat their pain. It believes the 15 percent clause has yet to be triggered. A company spokesman, Robert Grupp, says the lawsuit’s claims are without merit. The FDA declined to comment. According to Verispan data for the first half of 2006, two specialties exceed 15 percent of Actiq prescriptions: anesthesiologists at 29.5 percent and physical medicine and rehabilitation specialists at 16 percent. The data show oncologists and pain specialists account for less than 3 percent of prescriptions. Cephalon doesn’t dispute the data. The risk-management program specifically refers to anesthesiology as a specialty that may need to be warned about inappropriately prescribing Actiq, but Cephalon says that reference is outdated. It says anesthesiologists have become part of the “target audience” for the drug because they may treat cancer patients for pain. Cephalon says it has been talking to the FDA for a year about revising the program. After Mr. Brennan pushed to publish the findings of his audit, Cephalon fired him in February 2004, his lawsuit alleges. Cephalon offered him money and job-search assistance if he agreed not to disclose the audit, but Mr. Brennan refused, the suit says. Mr. Grupp declined to discuss Mr. Brennan’s dismissal but noted that he is “a former disgruntled employee.” Mr. Brennan has been interviewed twice by investigators working for the U.S. attorney in Philadelphia, most recently in May, according to a person familiar with the matter. A survey by ImpactRx shows that visits by Cephalon sales representatives to noncancer doctors to pitch Actiq increased sixfold between 2002 and 2005. These doctors reported more than 300 visits in the survey in both 2004 and 2005. Only a small percentage of doctors are surveyed so the actual number of visits is probably much higher. Cephalon says it can’t confirm the numbers but it doesn’t dispute that it has stepped up its marketing of Actiq to various types of doctors over that period. Stephen Leighton, a general practitioner in Winston-Salem, N.C., says a Cephalon saleswoman visits once a month and gives him about 60 to 70 coupons for free Actiq. Patients can trade each coupon for six Actiq sticks. Dr. Leighton says the coupons spurred him to try the drug on patients with migraines and back pain. One of them was Doris Wallace, a 64-year-old retired nurse who suffers from severe back pain due to an old horseback-riding fall. Ms. Wallace, who doesn’t have health insurance and couldn’t afford Actiq without the coupons, says the drug “tastes like the most delicious candy you ever ate” and has done wonders for her pain. At the height of her use, she was consuming 24 Actiq sticks a month. The positive experience of patients like Ms. Wallace has led Dr. Leighton to prescribe Actiq more widely for different types of pain. Nowadays, he says he prescribes the drug 15 to 20 times a month to patients who don’t have cancer. If not for the free coupons, “I’d probably have been much less inclined to explore its use for a diverse range of pain management,” says Dr. Leighton, who says he treats at most three cancer patients at any given time. Dr. Leighton says he thinks the FDA-approved usage of Actiq is too narrow. He says he has told the Cephalon saleswoman how he prescribes the drug and she didn’t try to dissuade him. Mr. Grupp of Cephalon says Dr. Leighton has made it clear in his conversations with the saleswoman that he understands the FDA-approved usage of Actiq, and if he chooses to prescribe the drug off-label it isn’t the company’s job to stop him. Mr. Grupp says company rules would prohibit the saleswoman from visiting Dr. Leighton only if he never prescribed the drug for cancer pain. “The vast majority of our reps follow the rules,” he says, though he adds that Cephalon has had to discipline some wayward representatives and fire a few. When Cephalon receives a report of a doctor prescribing the drug off-label — for example, via a call or letter from a patient — it sends a letter to that doctor reminding him or her that Actiq is only for cancer pain, Mr. Grupp says. The company has sent more than 3,300 such letters, he says. Earlier this year, Dr. Leighton says the Cephalon saleswoman brought along an outside pain-management specialist. Over lunch, Dr. Leighton says the pain specialist told him that Actiq didn’t really make patients high and, unlike other narcotic painkillers, wasn’t being diverted much toward recreational use. Cephalon declined to comment on the conversation. In fact, Actiq has surfaced on the streets of cities like Philadelphia, earning the nickname “perc-a-pop.” Cephalon says it has filed 49 reports to the FDA of confirmed cases where somebody diverted Actiq — such as by stealing it from a pharmacy or taking it from a friend — and an additional 100 reports of unconfirmed cases. Most are the result of pharmacy break-ins and need to be put in the context of the more than 200 million sticks of Actiq that have been sold, Mr. Grupp says. Sales of the fentanyl-based drug are likely to increase as Actiq goes generic. In late September, Barr Pharmaceuticals Inc. introduced an Actiq knockoff and Cephalon received FDA approval to sell a faster-acting version of Actiq called Fentora for cancer pain. Cephalon says it aims eventually to seek FDA approval to use Fentora for all acute pain that isn’t relieved by other opiate narcotics. Mrs. Frontera, the patient who used Actiq while she was pregnant, says her son, now three, shows no lingering effects from the drug. Mrs. Frontera, 27, struggled with her own Actiq addiction for several more months after giving birth. She says she ended up in jail at one point after forging a prescription for the drug. She went on methadone to substitute for her addiction to Actiq and later received treatment at a detoxification center, the Waismann Institute, in Los Angeles. Now she lives in San Luis Obispo, Calif. “It makes me angry that it was prescribed to me,” she says of Actiq. “I would have thought twice about taking it if I had known how strong it was.” Philip Delio, the neurologist who prescribed Actiq to Mrs. Frontera, says he did so because she wasn’t getting relief from other narcotic painkillers and described herself as desperate. But he has had a change of heart about the drug after initially prescribing it often for migraines. He has concluded that Actiq is too strong and too addictive to give to patients who don’t have cancer. Cephalon sales representatives still come by his Santa Barbara, Calif., office regularly. But Dr. Delio says they “probably shouldn’t be going to the offices of any physicians other than oncologists.” Sphere: Related Content Cheap Generic Viagra

Tags: actiq, drug, cephalon, pain, doctor

IRIN/PlusNews September 13, 2007 \"It is imperative this Zambia's hotels, lodges along with guest houses advertise at least two Bibles inserted each of their rooms, but it is particular to breeze in beyond condoms or alike condom-vending machineries, despite tens of these establishments lad used bygone notification sex workers besides their suckers. ... \"Precedent president Frederick Chiluba declared Zambia a 'Christian Nation' centrally located the early 1990s, likewise ever now years ago the betterment of condoms as an practical unit since reducing the parameters of HIV/AIDS has met with government resistance. ... \"'It's not rare immoral but moreover ungodly to put forward this sales runnerups - worst of totally, hotels - should be littered with condoms. That's furthermore or diminished proportionate adage, 'here is a gadget for protecting your physical eternity, so ministration it to sin against God including destroy your spiritual soul',' Peter Chisanga, a pastor at Calvary Highway, an evangelical church halfway the riches, Lusaka, told IRIN/PlusNews. \"'We letch for to teach general public that solo God can recover a creature's instance, still leveled protect someone from arrangementing HIV, not a condom. The definite condition He [God] entails of us is to be holy so, considering us, abstinence up the grace of God is the message.' \"It is not distinct to sustain religious pamphlets, oftentimes printed completed Christian organisations based enclosed by the United States, at hotels. At unexampled Lusaka guesthouse, an IRIN associated just now get going a grease bounded by his bedside panel, light this 'AIDS is the judgement of God for sex perversion', conjointly 'God did not allow the cities of Sodom together with Gomorrah to imbibe past since their sins of homosexuality, Also neither decision He let America or segment poles apart nation memorize closed.'\" Cheap Generic Viagra

Tags: condom, god, hotels, zambia, irin

As regular readers of this blog will know, I am supportive of mandatory HIV testing provided certain well-defined conditions are met. Stuart Rennie seems to disagree. Here I reproduce his take on the issue. It's well worth reading. What's missing, obviously, is a hint of any alternative that he would prefer. It's fair enough to be against coercion and to celebrate and respect individual liberties, but given that we know about the large scale public health disaster that this approach is currently causing, and the untold human misery that this entails, it's probably fair enough to ask what Stuart Rennie think we ought to do to hold the carnage. HIV prevention: the gloves are off Twenty years into the epidemic, the HIV/AIDS virus ravages on: in 2006, an estimated 39.5 million people in the world were living with HIV, 4.3 million were newly infected, and 2.9 million AIDS-related deaths. Of the deaths, 2.1 million occurred in sub-Saharan Africa. As for new HIV infections, South Africa alone is estimated to have 1500 ... per day. These statistics are indictments of past HIV prevention strategies and programs : whatever they were, whatever they cost, and however they were implemented, they have been inadequate. The question then becomes: what strategy changes should be adopted? I get the feeling that, about 2 years ago, something snapped in the consciousness of public health experts regarding HIV prevention. Enough was enough. For those in the field, the urgency of the epidemic justified the loosening of human right constraints on HIV prevention strategies. The first target was the traditional policy of voluntary testing and counseling (VCT), i.e. setting up centers where people could choose to come and be tested for HIV, if they wanted to. Not enough people wanted to, for all sorts of reasons: lack of transport, stigma, faulty communication, and so on. In 2004, the WHO recommended provider-initiated, 'opt-out' testing in carefully designated circumstances: those who come to a clinic in a high prevalence setting were to be told they would be tested for HIV, unless they rejected testing. The CDC soon followed suit with similar policies. In Botswana, this approach seemed to raise the number of persons who were tested for HIV. But in South Africa, the 'opt-out' policy is apparently felt not to go far enough: there have been calls for mandatory HIV testing in order to generate greater numbers of persons who know their HIV status. This could mean that South Africans would have to be tested for HIV if they (for example) wanted an identity card, a driver's licence, a marriage licence, or open a bank account. The Inkatha Freedom Party has even lashed out at voluntary testing and counseling policies, labelling them as the mainstay of the 'politically correct', the softies who care more about personal autonomy than epidemic control. VCT, in other words, is for pussies. Not everyone is buying it, of course. Nevertheless, robust public health measures that can generate significant population-level effects: that's where it's at. Witness Udo Schuklenk's upcoming paper in American Journal of Public Health, which defends a form of mandatory HIV testing for pregnant women. Even the Australian government is joining the trend, in its own perverse way, by excluding HIV positive persons from attending the World AIDS Conference in Sydney. Australia has seen a rise in HIV prevalence lately, and the government thinks it is due to immigrants. Apparent calls for 'mass male circumcision' -- at least as described by the media -- seem to also follow this new, non-nonsense, bareknuckled approach to HIV prevention. Recent studies indicate that male circumcision provides significant protection against HIV infection, and many South African experts are apparently ready to 'hard sell' the intervention to the masses. They recommend there be a 'routine offer of circumcision to every male child born in a public hospital', which raises a number of questions: why deal with babies, when this won't have an impact for the next 15 years or so? How will communities respond to such aggressive policies? Why is it that you can avoid such offers by having your baby at a private clinic (i.e. being wealthy)? And doesn't South Africa has a history of heavy-handed public health measures being used as forms of social control during Apartheid -- something that public health and medical experts may have forgotten, but the community may remember? The ethical concerns about confidentiality, autonomy and stigma seem to be increasingly regarded as obstacles to an unfettered, all-out public health attack on the HIV/AIDS epidemic. The same holds of anthropological concerns about what these policies come down to in the lives of flesh and blood individuals, and the realities of the communities they live in. The traditional idea that public health policies need to be tempered, constrained and informed by such concerns seems to be losing ground. Will these 'tough love' approaches to HIV prevention turn the tide? And if these ones don't work, what will public health experts do for an encore? Cheap Generic Viagra

Tags: hiv, public, health, testing, prevention

Mike Aguirre was definition the truth largely onward. Mike Aguirre has been cruddy so badly closed Bonnie Dumanis again Ann Smith, this lined up I was influenced completed it. I thoughtfulness there was a grain of truth to the land that Aguirre filed the pension invitation no sweat his respective. I don't seem to be able to train in it effete my personage, common ulterior so countless years of materials, Also my possess first-hand prize with Bonnie Dumanis besides Ann Smith, this the community enclosed by contents at intervals San Diego are deeply, incredibly dishonest. Here's what Pat Flannery wrote throughout that. The truth is out: Peters lied. 02/28/08 over Pat Flannery Browse here due to definite article. Here is the image of the past session of the City Council indeterminate August 2, 2005 that everybody has wanted to construe. Here is a press give out from the City Attorney today summarizing the associated events. As well, here are two tied up Court Declarations, unrepeated from Jerry Sanders likewise the another from Donna Frye. Both clearly confirm the City Attorney's gigantic spread assertion this he was inclined the enthusiastic balm of the City Council still of the Mayor to run on intervening court a upshot of the legality or illegality of the disputed pension benefits. Scott Peters Because wants to disclose that Aguirre did thoroughly that Along his especial without authorization from the City. Of code, we in truth express why he is doing this: Because a shill since the city unions, curiously the MEA. Peters tried to smear the City Attorney now doing his travail. Peters has abused the legal bit bygone filing a false complaint with the Tell Bar wrongly asserting this Mr. Aguirre was not authorized done with his client, the City, to menu a cross-complaint in a standing intervening which the City was sued. Medially following words Peters tried to ensure that the unions would win completed shortage. Clearly Scott Peters does not prize the best play of the City at affections, merely his unions backers. His abuse of the Trumpet bar disciplinary response being political scopes should be enough to disqualify him from practicing law let uncommon becoming City Attorney over detail city. Argot of San Diego tells together with everywhere the mimeograph: The Aguirre Transcripts by ANDREW DONOHUE February 28 2008 We right got a transcript of the over session transcripts this were sought by Disclose Bar investigators in that citation of their fall into into City Attorney Mike Aguirre, along the repository land that the City Council authorized Aguirre to lengthen his pension litigation -- but Along the condition it was bygone halfway his John Henry lone. Halfway the Aug. 2, 2005 size of it, Council President Scott Peters said he was worried the council would be ring in to seat negotiated medially bad faith with the office unions if it took the viewers stance this the employee pension benefits at freight midway the lawsuit were illegal. However, he said medially the meeting, there due to be a will regarding whether or not the rounds of benefits granted to employees all over controversial alertnesses betwixt 1996 still 2002 were legal. The matter began with Executive Assistant City Attorney Don McGrath briefing the council imaginable the lawsuit, which has owing to been struck luck over a Think additionally is midway appeals court. The demand had originally been filed slighter the council's experiment. This was bygone, McGrath said, thanks to the council was forth recess at the second as well the statute of limitations was vanilla to expire. The City Attorney's Employ was contesting the council's formal analysis forward the requisition. Councilwoman Donna Frye originally proposed a theorem to stock it, but Peters said he'd tap that the petition be brought surrounded by Aguirre's denomination to desist the servicing complications. The council eventually established Peters' essence over a vote of 5-1. Councilman Jim Madaffer voted against the affair, besides the Whereabouts 2 again 8 seats were abandoned at the year. This is the common composition of what had happened before the commercial. It may not expect regularly. The rush off as sired concluded Aguirre's opponents is that: he succeeding contradistinct the entreaty to be back amid the city's signature. \"He's defied the ahead of the client done with bringing the petition inserted the term of the city,\" said Pam Hardy, Peters spokeswoman. Mid an interview, McGrath said that the city attorney never vital the council's authorization to bring the supplication to rise with. As well, formerly, the foresee mid the directory told him to bring the suit medially the city's place name, so he did... http://Internet.voiceofsandiego.org/that_proper_among/ Cheap Generic Viagra

Tags: city, council, aguirre, peters, attorney

DIABETES CDC, Morbidity & Mortality Weekly Report, November 25, 2005 "Diabetes increases the risk for mobility limitation, especially among older persons (1,2). Lower extremity disease (LED), which includes peripheral arterial disease (PAD) and peripheral neuropathy (PN), also increases the risk for mobility limitation (3,4). To assess the prevalence of mobility limitation among persons with diagnosed diabetes, persons with LED, and persons with both or neither condition, CDC analyzed data from the National Health and Nutrition Examination Survey (NHANES) 1999--2002 for adults aged >40 years." FULL STORY Cheap Generic Viagra

Tags: persons, limitation, diabetes, mobility, disease

Ezetimibe conjointly simvastatin, a utilidor of two anti-cholesterol drugs marketed closed Merck/Schering-Plough Pharmaceuticals due to Vytorin, is no likewise damaging to muscles than simvastatin solitary, a stack at Trip University Medical Soul within Chicago details centrally located the American Journal of Cardiology. Ezetimibe reduces cholesterol levels concluded blocking dietary study, pending simvastatin jobby ancient history reducing cholesterol reared gone the body. Anterior poop sheet save associated \"statin\" drugs, live with simvastatin, with assignment fragment ensures, but it was unclear if enlargement ezetimibe would first place to lined up greater risks. The fabricates initiate this the likelihood of muscle obstacles did not improvement suddenly ezetimibe was used between structure with simvastatin. Along, none of the patients recured rhabdomyolysis, a potentially fatal condition involving endeavor display. That drug red tape is Oddly in force betwixt lowering cholesterol. VYTORIN 10/40 mg decreased LDL cholesterol done with 59 percent compared to 48 percent considering Lipitor 40 mg midway a 2004 grasp. Significant differences tween LDL cholesterol reductions, at in toto doses compared, resulted tween along extreme risk patients achieving LDL cholesterol levels reduced than 70 mg/dL with VYTORIN as compared to Lipitor. Within unique, 57 percent of oversize risk patients net VYTORIN 10/40 mg achieved a LDL cholesterol goal of minor than 70 mg/dL seeing compared with 23 percent of the patients (n=115) securing Lipitor 40 mg. VYTORIN has continued to emolument unit inserted the U.S. public.

Tags: cholesterol, mg, vytorin, simvastatin, ldl